Nuveen Asset Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 207,972 shares of AMPH stock, worth $8.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207,972
Previous 301,589
31.04%
Holding current value
$8.49 Million
Previous $12.1 Million
16.34%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AMPH
# of Institutions
287Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$243 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$111 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$87.2 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$79.5 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$66 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...